Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Vertex Pharmaceuticals - 33 Year Stock Price History | VRTX

Historical daily share price chart and data for Vertex Pharmaceuticals since 1991 adjusted for splits and dividends. The latest closing stock price for Vertex Pharmaceuticals as of April 24, 2024 is 400.76.
  • The all-time high Vertex Pharmaceuticals stock closing price was 446.08 on January 30, 2024.
  • The Vertex Pharmaceuticals 52-week high stock price is 448.40, which is 11.9% above the current share price.
  • The Vertex Pharmaceuticals 52-week low stock price is 320.01, which is 20.1% below the current share price.
  • The average Vertex Pharmaceuticals stock price for the last 52 weeks is 374.82.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Vertex Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 417.9443 410.9100 446.0800 393.1000 400.7600 -1.51%
2023 339.1680 286.0200 410.6800 283.2300 406.8900 40.90%
2022 274.5959 222.5300 321.4800 221.4200 288.7800 31.50%
2021 204.4323 229.4300 241.3100 177.0100 219.6000 -7.08%
2020 251.5545 219.4500 303.1000 199.7700 236.3400 7.94%
2019 184.7418 164.0800 223.9100 163.7300 218.9500 32.13%
2018 167.4049 152.9100 192.7400 145.7200 165.7100 10.58%
2017 126.9038 74.8900 166.1100 74.8900 149.8600 103.42%
2016 88.1828 122.8900 123.4500 72.0200 73.6700 -41.45%
2015 123.7852 123.0700 141.4800 98.5000 125.8300 5.92%
2014 89.4849 73.8300 120.7800 62.4400 118.8000 59.89%
2013 68.0295 43.6500 88.5100 43.6500 74.3000 77.33%
2012 47.3818 32.2300 64.8500 32.2000 41.9000 26.17%
2011 44.0248 35.9900 58.0100 26.6000 33.2100 -5.20%
2010 36.8595 44.2400 44.2400 32.1500 35.0300 -18.25%
2009 33.6777 30.6900 43.5500 26.2300 42.8500 41.05%
2008 25.9329 23.1500 34.6800 14.5900 30.3800 30.78%
2007 31.3792 36.9000 40.5600 23.2300 23.2300 -37.92%
2006 35.8992 27.9000 45.1200 27.9000 37.4200 35.24%
2005 16.3817 10.2400 28.9200 8.8300 27.6700 161.78%
2004 10.0132 10.5000 11.9100 8.1700 10.5700 2.13%
2003 12.7675 16.3600 16.4000 8.0000 10.3500 -34.70%
2002 20.1402 24.5400 31.6100 12.9500 15.8500 -35.54%
2001 38.1837 63.1300 74.1900 16.5200 24.5900 -65.61%
2000 51.5357 18.7500 97.2500 16.7500 71.5000 308.57%
1999 13.1561 14.7200 17.5450 9.9400 17.5000 17.65%
1998 13.7489 16.6900 19.6250 7.6250 14.8750 -9.85%
1997 18.9003 19.1250 25.5650 12.8750 16.5000 -18.01%
1996 14.7045 13.0000 20.1250 11.0000 20.1250 51.89%
1995 8.4467 7.5000 13.2500 6.3750 13.2500 76.67%
1994 7.1147 9.0600 9.6250 5.2500 7.5000 -18.92%
1993 5.5591 5.1250 9.3750 3.3750 9.2500 89.74%
1992 5.3817 7.5000 8.6250 3.3750 4.8750 -33.90%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $104.653B $9.869B
Vertex Pharmaceuticals Incorporated is focused on the discovery, development, and commercialization of small molecule drugs targeting serious diseases. The company's main area of focus is cystic fibrosis. The company's lead marketed products are Trikafta, Symdeko/Symkevi, Orkambi and Kalydeco, which are collectively approved to treat the people with CF in North America, Europe and Australia. Trikafta, Vertex's triple combination regimen, was approved by the FDA for the treatment of CF in people aged 12 years and older who have at least one F508del mutation. While CF remains the main area of focus, Vertex is also developing treatments for sickle cell disease, beta thalassemia, APOL1-mediated kidney disease, type 1 diabetes, pain, alpha-1 antitrypsin deficiency and muscular dystrophies. Pimodivir/VX-787, for the treatment of influenza, was out-licensed to Janssen while oncology candidates VX-970, VX-984 and VX-803 were divested to Merck KGaA.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $146.720B 14.67
Regeneron Pharmaceuticals (REGN) United States $99.589B 24.14
Bristol Myers Squibb (BMY) United States $99.291B 6.53
CSL (CSLLY) Australia $87.672B 0.00
GSK (GSK) United Kingdom $85.467B 10.71
Gilead Sciences (GILD) United States $83.458B 9.97
Moderna (MRNA) United States $41.309B 0.00
Biogen (BIIB) United States $28.081B 13.11
Argenex SE (ARGX) Netherlands $22.291B 0.00
BioNTech SE (BNTX) Germany $21.036B 21.48
Illumina (ILMN) United States $19.821B 143.06
Genmab (GMAB) Denmark $18.885B 24.20
Alnylam Pharmaceuticals (ALNY) United States $18.397B 0.00
BioMarin Pharmaceutical (BMRN) United States $17.375B 73.65
BeiGene (BGNE) Cayman Islands $13.293B 0.00
Incyte (INCY) United States $11.597B 19.27
Exact Sciences (EXAS) United States $11.533B 0.00
Sarepta Therapeutics (SRPT) United States $10.998B 0.00
Bio-Techne Corp (TECH) United States $10.012B 37.25
Repligen (RGEN) United States $9.564B 99.01
QIAGEN (QGEN) Netherlands $9.559B 19.79
Roivant Sciences (ROIV) United Kingdom $8.816B 0.00
Legend Biotech (LEGN) United States $8.632B 0.00
Ascendis Pharma (ASND) Denmark $8.433B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.983B 23.78
Intra-Cellular Therapies (ITCI) United States $7.165B 0.00
Viking Therapeutics (VKTX) United States $7.156B 0.00
Exelixis (EXEL) United States $6.866B 36.39
Cytokinetics (CYTK) United States $6.857B 0.00
Vaxcyte (PCVX) United States $6.621B 0.00
Apellis Pharmaceuticals (APLS) United States $5.875B 0.00
Blueprint Medicines (BPMC) United States $5.648B 0.00
Halozyme Therapeutics (HALO) United States $4.951B 15.28
CRISPR Therapeutics AG (CRSP) Switzerland $4.788B 0.00
Krystal Biotech (KRYS) United States $4.621B 0.00
Zealand Pharma (ZLDPF) Denmark $4.434B 0.00
Nuvalent (NUVL) United States $4.331B 0.00
Immunovant (IMVT) United States $4.157B 0.00
Alkermes (ALKS) Ireland $4.104B 21.66
Insmed (INSM) United States $3.754B 0.00
ImmunityBio (IBRX) United States $3.717B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.713B 0.00
Biohaven (BHVN) United States $3.496B 0.00
Axsome Therapeutics (AXSM) United States $3.462B 0.00
Iovance Biotherapeutics (IOVA) United States $3.313B 0.00
Fortrea Holdings (FTRE) United States $3.301B 0.00
SpringWorks Therapeutics (SWTX) United States $3.247B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.180B 0.00
Amicus Therapeutics (FOLD) United States $3.164B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.100B 0.00
IDEAYA Biosciences (IDYA) United States $2.917B 0.00
Apogee Therapeutics (APGE) United States $2.909B 0.00
Arcellx (ACLX) United States $2.901B 0.00
Immunocore Holdings (IMCR) United Kingdom $2.855B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.763B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.758B 0.00
MorphoSys AG (MOR) Germany $2.717B 0.00
Certara (CERT) United States $2.680B 57.69
Janux Therapeutics (JANX) United States $2.572B 0.00
CG Oncology (CGON) United States $2.420B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.406B 0.00
Merus (MRUS) Netherlands $2.396B 0.00
Arvinas (ARVN) United States $2.322B 0.00
Denali Therapeutics (DNLI) United States $2.296B 0.00
Vericel (VCEL) United States $2.246B 0.00
Kymera Therapeutics (KYMR) United States $2.182B 0.00
Vera Therapeutics (VERA) United States $2.152B 0.00
Rocket Pharmaceuticals (RCKT) United States $2.142B 0.00
Celldex Therapeutics (CLDX) United States $2.111B 0.00
Guardant Health (GH) United States $2.111B 0.00
Intellia Therapeutics (NTLA) United States $2.076B 0.00
Avidity Biosciences (RNA) United States $2.004B 0.00
Keros Therapeutics (KROS) United States $1.991B 0.00
Galapagos (GLPG) Belgium $1.941B 0.00
Beam Therapeutics (BEAM) United States $1.932B 0.00
Geron (GERN) United States $1.914B 0.00
Ginkgo Bioworks Holdings (DNA) United States $1.874B 0.00
Twist Bioscience (TWST) United States $1.821B 0.00
NeoGenomics (NEO) United States $1.808B 0.00
Sana Biotechnology (SANA) United States $1.783B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.782B 0.00
Myriad Genetics (MYGN) United States $1.683B 0.00
Structure Therapeutics (GPCR) United States $1.682B 0.00
Bavarian Nordic (BVNRY) Denmark $1.675B 5.50
Harmony Biosciences Holdings (HRMY) United States $1.638B 13.61
Neumora Therapeutics (NMRA) United States $1.637B 0.00
Inhibrx (INBX) United States $1.618B 0.00
Protagonist Therapeutics (PTGX) United States $1.565B 0.00
Dynavax Technologies (DVAX) United States $1.539B 0.00
Zai Lab (ZLAB) China $1.500B 0.00
ADMA Biologics Inc (ADMA) United States $1.493B 0.00
Edgewise Therapeutics (EWTX) United States $1.457B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.454B 0.00
Akero Therapeutics (AKRO) United States $1.452B 0.00
Morphic Holding (MORF) United States $1.439B 0.00
Kura Oncology (KURA) United States $1.427B 0.00
Arcus Biosciences (RCUS) United States $1.408B 0.00
ANI Pharmaceuticals (ANIP) United States $1.394B 17.14
Gyre Therapeutics (GYRE) United States $1.362B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.260B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.248B 0.00
Spyre Therapeutics (SYRE) United States $1.238B 0.00
Ligand Pharmaceuticals (LGND) United States $1.237B 15.33
Autolus Therapeutics (AUTL) United Kingdom $1.191B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.185B 0.00
AbCellera Biologics (ABCL) Canada $1.162B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.154B 0.00
Scholar Rock Holding (SRRK) United States $1.152B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.148B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.133B 0.00
MannKind (MNKD) United States $1.126B 0.00
Prothena (PRTA) Ireland $1.104B 0.00
Vir Biotechnology (VIR) United States $1.093B 0.00
Belite Bio (BLTE) United States $1.079B 0.00
Abivax SA (ABVX) France $0.998B 0.00
Liquidia Technologies (LQDA) United States $0.985B 0.00
MiMedx (MDXG) United States $0.957B 217.00
Viridian Therapeutics (VRDN) United States $0.894B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.892B 0.00
Immatics (IMTX) Germany $0.882B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.876B 0.00
Immunome (IMNM) United States $0.875B 0.00
Tyra Biosciences (TYRA) United States $0.860B 0.00
89BIO (ETNB) United States $0.849B 0.00
Arcutis Biotherapeutics (ARQT) United States $0.846B 0.00
Tango Therapeutics (TNGX) United States $0.829B 0.00
Kyverna Therapeutics (KYTX) United States $0.827B 0.00
REGENXBIO (RGNX) United States $0.780B 0.00
ALX Oncology Holdings (ALXO) United States $0.775B 0.00
Cytek Biosciences (CTKB) United States $0.760B 0.00
Pliant Therapeutics (PLRX) United States $0.755B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.752B 0.00
CARGO Therapeutics (CRGX) United States $0.748B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.730B 0.00
Cullinan Therapeutics (CGEM) United States $0.718B 0.00
PureTech Health (PRTC) United States $0.706B 0.00
Nurix Therapeutics (NRIX) United States $0.695B 0.00
Dianthus Therapeutics (DNTH) United States $0.687B 0.00
Mesoblast (MESO) Australia $0.684B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.681B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.672B 0.00
Cogent Biosciences (COGT) United States $0.665B 0.00
EnGene Holdings (ENGN) United States $0.665B 0.00
Disc Medicine (IRON) United States $0.652B 0.00
Aerovate Therapeutics (AVTE) United States $0.647B 0.00
Praxis Precision Medicines (PRAX) United States $0.647B 0.00
Pharming Group (PHAR) Netherlands $0.644B 0.00
Cabaletta Bio (CABA) United States $0.643B 0.00
HilleVax (HLVX) United States $0.637B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.623B 0.00
WAVE Life Sciences (WVE) Singapore $0.621B 0.00
Pharming Group (PHGUF) Netherlands $0.620B 0.00
Zymeworks (ZYME) United States $0.604B 0.00
Oric Pharmaceuticals (ORIC) United States $0.591B 0.00
GH Research (GHRS) Ireland $0.588B 0.00
Novavax (NVAX) United States $0.586B 0.00
Nuvation Bio (NUVB) United States $0.584B 0.00
CureVac (CVAC) Germany $0.582B 0.00
Prime Medicine (PRME) United States $0.576B 0.00
Allogene Therapeutics (ALLO) United States $0.570B 0.00
Northwest Biotherapeutics (NWBO) United States $0.568B 0.00
Mineralys Therapeutics (MLYS) United States $0.567B 0.00
Olema Pharmaceuticals (OLMA) United States $0.559B 0.00
Castle Biosciences (CSTL) United States $0.551B 0.00
Absci (ABSI) United States $0.531B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.530B 0.00
Astria Therapeutics (ATXS) United States $0.529B 0.00
ArriVent BioPharma (AVBP) United States $0.528B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.527B 0.00
Celcuity (CELC) United States $0.525B 0.00
Stoke Therapeutics (STOK) United States $0.521B 0.00
Fate Therapeutics (FATE) United States $0.517B 0.00
AnaptysBio (ANAB) United States $0.513B 0.00
Alector (ALEC) United States $0.511B 0.00
Applied Therapeutics (APLT) United States $0.510B 0.00
Arbutus Biopharma (ABUS) United States $0.494B 0.00
Oculis Holding AG (OCS) Switzerland $0.485B 0.00
C4 Therapeutics (CCCC) United States $0.473B 0.00
Humacyte (HUMA) United States $0.468B 0.00
Fulcrum Therapeutics (FULC) United States $0.462B 0.00
Adlai Nortye (ANL) Cayman Islands $0.460B 0.00
ACELYRIN, INC (SLRN) United States $0.455B 0.00
IGM Biosciences (IGMS) United States $0.453B 0.00
Shattuck Labs (STTK) United States $0.451B 0.00
Third Harmonic Bio (THRD) United States $0.450B 0.00
Editas Medicine (EDIT) United States $0.449B 0.00
Travere Therapeutics (TVTX) United States $0.437B 0.00
Entrada Therapeutics (TRDA) United States $0.433B 0.00
Avid Bioservices (CDMO) United States $0.422B 0.00
Voyager Therapeutics (VYGR) United States $0.415B 2.48
ADC Therapeutics SA (ADCT) Switzerland $0.412B 0.00
Neurogene (NGNE) United States $0.401B 0.00
Annexon (ANNX) United States $0.400B 0.00
MaxCyte (MXCT) United States $0.397B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.396B 0.00
Replimune (REPL) United States $0.394B 0.00
Biomea Fusion (BMEA) United States $0.394B 0.00
ITeos Therapeutics (ITOS) United States $0.394B 0.00
Mersana Therapeutics (MRSN) United States $0.389B 0.00
Anika Therapeutics (ANIK) United States $0.383B 0.00
Revance Therapeutics (RVNC) United States $0.381B 0.00
PepGen (PEPG) United States $0.379B 0.00
Adaptive Biotechnologies (ADPT) United States $0.374B 0.00
Nkarta (NKTX) United States $0.374B 0.00
Alto Neuroscience (ANRO) United States $0.373B 0.00
Amarin (AMRN) Ireland $0.363B 0.00
FibroBiologics (FBLG) United States $0.362B 0.00
Caribou Biosciences (CRBU) United States $0.359B 0.00
Aura Biosciences (AURA) United States $0.357B 0.00
Tenaya Therapeutics (TNYA) United States $0.349B 0.00
Precigen (PGEN) United States $0.348B 0.00
TScan Therapeutics (TCRX) United States $0.348B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.347B 0.00
Solid Biosciences (SLDB) United States $0.345B 0.00
Urogen Pharma (URGN) United States $0.341B 0.00
Rani Therapeutics Holdings (RANI) United States $0.336B 0.00
Jasper Therapeutics (JSPR) United States $0.333B 0.00
Ocugen (OCGN) United States $0.322B 0.00
MeiraGTx Holdings (MGTX) United States $0.317B 0.00
Atea Pharmaceuticals (AVIR) United States $0.314B 0.00
Nautilus Biotechnology (NAUT) United States $0.311B 0.00
Ventyx Biosciences (VTYX) United States $0.307B 0.00
XOMA (XOMA) United States $0.304B 0.00
Terns Pharmaceuticals (TERN) United States $0.303B 0.00
Anavex Life Sciences (AVXL) United States $0.302B 0.00
CorMedix Inc (CRMD) United States $0.299B 0.00
Kamada (KMDA) Israel $0.293B 22.13
Erasca (ERAS) United States $0.292B 0.00
Contineum Therapeutics (CTNM) United States $0.290B 0.00
Renovaro (RENB) United States $0.290B 0.00
Werewolf Therapeutics (HOWL) United States $0.279B 0.00
Rapt Therapeutics (RAPT) United States $0.278B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.278B 0.00
Inozyme Pharma (INZY) United States $0.272B 0.00
Invivyd (IVVD) United States $0.271B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.266B 92.60
Oxford BioMedica (OXBDF) United Kingdom $0.262B 0.00
ChromaDex (CDXC) United States $0.256B 0.00
XBiotech (XBIT) United States $0.249B 0.00
Coherus BioSciences (CHRS) United States $0.247B 0.00
Puma Biotechnology (PBYI) United States $0.247B 11.15
Verastem (VSTM) United States $0.243B 0.00
Inovio Pharmaceuticals (INO) United States $0.242B 0.00
23andMe Holding (ME) United States $0.238B 0.00
2seventy Bio (TSVT) United States $0.238B 0.00
AC Immune (ACIU) Switzerland $0.235B 0.00
Sutro Biopharma (STRO) United States $0.232B 0.00
Adverum Biotechnologies (ADVM) United States $0.228B 0.00
UniQure (QURE) Netherlands $0.227B 0.00
Ovid Therapeutics (OVID) United States $0.226B 0.00
Prima BioMed (IMMP) Australia $0.221B 0.00
G1 Therapeutics (GTHX) United States $0.219B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.214B 0.00
Elevation Oncology (ELEV) United States $0.210B 0.00
Compass Therapeutics (CMPX) United States $0.209B 0.00
Poseida Therapeutics (PSTX) United States $0.208B 0.00
Design Therapeutics (DSGN) United States $0.207B 0.00
X4 Pharmaceuticals (XFOR) United States $0.207B 0.00
Codexis (CDXS) United States $0.204B 0.00
Trevi Therapeutics (TRVI) United States $0.197B 0.00
Opthea (OPT) Australia $0.196B 0.00
Lifecore Biomedical (LFCR) United States $0.196B 0.00
Innate Pharma S.A (IPHA) France $0.192B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.190B 0.00
Alimera Sciences (ALIM) United States $0.188B 0.00
Akoya Biosciences (AKYA) United States $0.187B 0.00
Cardiff Oncology (CRDF) United States $0.186B 0.00
INmune Bio (INMB) United States $0.185B 0.00
Kodiak Sciences (KOD) United States $0.175B 0.00
Candel Therapeutics (CADL) United States $0.173B 0.00
Skye Bioscience (SKYE) United States $0.173B 0.00
Inventiva S.A (IVA) France $0.173B 0.00
Adicet Bio (ACET) United States $0.173B 0.00
GENFIT S.A (GNFT) France $0.172B 0.00
Compugen (CGEN) Israel $0.172B 0.00
Greenwich LifeSciences (GLSI) United States $0.169B 0.00
Adocia (ADOCY) France $0.169B 0.00
Gossamer Bio (GOSS) United States $0.166B 0.00
ScPharmaceuticals (SCPH) United States $0.166B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.164B 0.00
Scilex Holding (SCLX) United States $0.162B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.162B 0.00
Zura Bio (ZURA) United States $0.150B 0.00
BioStem Technologies (BSEM) $0.150B 0.00
CervoMed (CRVO) United States $0.150B 0.00
Cellectis S.A (CLLS) France $0.146B 0.00
I-Mab (IMAB) China $0.145B 0.00
Molecular Partners AG (MOLN) Switzerland $0.141B 0.00
Syros Pharmaceuticals (SYRS) United States $0.137B 0.00
Sagimet Biosciences (SGMT) United States $0.137B 0.00
Agenus (AGEN) United States $0.135B 0.00
DBV Technologies S.A (DBVT) France $0.131B 0.00
Annovis Bio (ANVS) United States $0.131B 0.00
VistaGen Therapeutics (VTGN) United States $0.131B 0.00
Omega Therapeutics (OMGA) United States $0.129B 0.00
Vor Biopharma (VOR) $0.128B 0.00
Repare Therapeutics (RPTX) Canada $0.124B 0.00
Emergent Biosolutions (EBS) United States $0.120B 0.00
PDS Biotechnology (PDSB) United States $0.117B 0.00
Seer (SEER) United States $0.117B 0.00
Coya Therapeutics (COYA) United States $0.117B 0.00
Nuvectis Pharma (NVCT) United States $0.117B 0.00
Adagene (ADAG) China $0.117B 0.00
Seres Therapeutics (MCRB) United States $0.115B 0.00
Rezolute (RZLT) United States $0.115B 0.00
CytomX Therapeutics (CTMX) United States $0.114B 0.00
Immunic (IMUX) United States $0.112B 0.00
Cartesian Therapeutics (RNAC) United States $0.111B 0.00
TELA Bio (TELA) United States $0.110B 0.00
ATyr Pharma (LIFE) United States $0.110B 0.00
BioXcel Therapeutics (BTAI) United States $0.110B 0.00
Sangamo Therapeutics (SGMO) United States $0.108B 0.00
BioAtla (BCAB) United States $0.108B 0.00
Oncobiologics (OTLK) United States $0.107B 0.00
Bluebird Bio (BLUE) United States $0.106B 0.00
BioHarvest Sciences (CNVCF) Canada $0.105B 0.00
Clearside Biomedical (CLSD) United States $0.102B 0.00
Vigil Neuroscience (VIGL) United States $0.100B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.099B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.098B 0.00
IO Biotech (IOBT) Denmark $0.097B 0.00
Elicio Therapeutics (ELTX) United States $0.094B 0.00
Genelux (GNLX) United States $0.093B 0.00
Abeona Therapeutics (ABEO) United States $0.093B 0.00
Allakos (ALLK) United States $0.092B 0.00
DiaMedica Therapeutics (DMAC) United States $0.092B 0.00
Galena Biopharma (SLS) United States $0.092B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.090B 0.00
BeyondSpring (BYSI) United States $0.089B 0.00
Curis (CRIS) United States $0.088B 0.00
Atara Biotherapeutics (ATRA) United States $0.086B 0.00
Eton Pharmaceuticals (ETON) United States $0.084B 0.00
Q32 Bio (QTTB) United States $0.083B 0.00
Leap Therapeutics (LPTX) United States $0.082B 0.00
Eupraxia Pharmaceuticals (EPRX) $0.082B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.082B 0.00
Affimed (AFMD) Germany $0.081B 0.00
Aileron Therapeutics (ALRN) United States $0.081B 0.00
InflaRx (IFRX) Germany $0.080B 0.00
Oncolytics Biotech (ONCY) Canada $0.080B 0.00
Athira Pharma (ATHA) United States $0.078B 0.00
Cognition Therapeutics (CGTX) United States $0.078B 0.00
Spero Therapeutics (SPRO) United States $0.077B 2.87
Connect Biopharma Holdings (CNTB) United States $0.077B 0.00
Passage Bio (PASG) United States $0.076B 0.00
HOOKIPA Pharma (HOOK) United States $0.076B 0.00
YS Biopharma (YS) China $0.075B 0.00
VTv Therapeutics (VTVT) United States $0.075B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.075B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.074B 0.00
Alpha Teknova (TKNO) United States $0.073B 0.00
Cue Biopharma (CUE) United States $0.073B 0.00
Gritstone Bio (GRTS) United States $0.072B 0.00
Turnstone Biologics (TSBX) United States $0.071B 0.00
Precision BioSciences (DTIL) United States $0.071B 0.00
AN2 Therapeutics (ANTX) United States $0.071B 0.00
Instil Bio (TIL) United States $0.070B 0.00
Elutia (ELUT) United States $0.070B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.069B 0.00
Landos Biopharma (LABP) United States $0.069B 0.00
Genenta Science S.p.A (GNTA) Italy $0.066B 0.00
Rallybio (RLYB) United States $0.066B 0.00
MediciNova (MNOV) United States $0.065B 0.00
Ikena Oncology (IKNA) United States $0.065B 0.00
Entera Bio (ENTX) Israel $0.064B 0.00
Aligos Therapeutics (ALGS) United States $0.062B 0.00
Celularity (CELU) United States $0.062B 0.00
Lantern Pharma (LTRN) United States $0.062B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.062B 0.00
Immix Biopharma (IMMX) United States $0.061B 0.00
HCW Biologics (HCWB) United States $0.061B 0.00
Equillium (EQ) United States $0.061B 0.00
Kezar Life Sciences (KZR) United States $0.060B 0.00
LENZ Therapeutics (LENZ) United States $0.058B 0.00
Kronos Bio (KRON) United States $0.057B 0.00
Enzo Biochem (ENZ) United States $0.056B 0.00
Intensity Therapeutics (INTS) United States $0.056B 0.00
AVROBIO (AVRO) United States $0.054B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.054B 0.00
ARCA Biopharma (ABIO) United States $0.053B 0.00
Ocean Biomedical (OCEA) United States $0.051B 0.00
Checkpoint Therapeutics (CKPT) United States $0.051B 0.00
CalciMedica (CALC) United States $0.049B 0.00
Quince Therapeutics (QNCX) United States $0.048B 0.00
Immuneering (IMRX) United States $0.048B 0.00
Cidara Therapeutics (CDTX) United States $0.047B 0.00
Aadi Bioscience (AADI) United States $0.045B 0.00
Beyond Air (XAIR) United States $0.044B 0.00
Bionano Genomics (BNGO) United States $0.043B 0.00
Dyadic (DYAI) United States $0.043B 0.00
Clene (CLNN) United States $0.043B 0.00
Apollomics (APLM) United States $0.043B 0.00
NextCure (NXTC) United States $0.043B 0.00
Carmell (CTCX) United States $0.042B 0.00
Bolt Biotherapeutics (BOLT) United States $0.042B 0.00
NKGen Biotech (NKGN) United States $0.042B 0.00
Prenetics Global (PRE) Cayman Islands $0.042B 0.00
OKYO Pharma (OKYO) $0.040B 0.00
SAB Biotherapeutics (SABS) United States $0.040B 0.00
Promis Neurosciences (PMN) Canada $0.039B 0.00
Cara Therapeutics (CARA) United States $0.039B 0.00
Ocuphire Pharma (OCUP) United States $0.038B 0.00
Estrella Immunopharma (ESLA) United States $0.038B 0.00
BRIACELL THERAP (BCTX) Canada $0.037B 0.00
Xilio Therapeutics (XLO) United States $0.036B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.036B 0.00
Fortress Biotech (FBIO) United States $0.035B 0.00
Cyclo Therapeutics (CYTH) United States $0.035B 0.00
Theratechnologies (THTX) Canada $0.033B 0.00
IN8bio (INAB) United States $0.033B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.032B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.031B 0.00
MiNK Therapeutics (INKT) United States $0.030B 0.00
Dare Bioscience (DARE) United States $0.030B 0.00
BioAffinity Technologies (BIAF) United States $0.030B 0.00
Femasys (FEMY) United States $0.029B 0.00
Aprea Therapeutics (APRE) United States $0.029B 0.00
Lexaria Bioscience (LEXX) Canada $0.029B 0.00
Spruce Biosciences (SPRB) United States $0.029B 0.00
Evogene (EVGN) Israel $0.027B 0.00
Forte Biosciences (FBRX) United States $0.027B 0.00
Semper Paratus Acquisition (TVGN) United States $0.026B 0.00
Pluri (PLUR) Israel $0.026B 0.00
Eyenovia (EYEN) United States $0.026B 0.00
Vaxxinity (VAXX) United States $0.025B 0.00
UNITY Biotechnology (UBX) United States $0.025B 0.00
Sensei Biotherapeutics (SNSE) United States $0.025B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.024B 0.00
Biora Therapeutics (BIOR) United States $0.023B 0.00
Lumos Pharma (LUMO) United States $0.023B 0.00
Synlogic (SYBX) United States $0.022B 0.00
Lisata Therapeutics (LSTA) United States $0.022B 0.00
Evaxion Biotech (EVAX) Denmark $0.022B 0.00
Vincerx Pharma (VINC) United States $0.020B 0.00
RenovoRx (RNXT) United States $0.020B 0.00
Aptose Biosciences (APTO) Canada $0.019B 0.00
Galecto (GLTO) Denmark $0.019B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.019B 0.00
KALA BIO (KALA) United States $0.018B 0.00
Orgenesis (ORGS) United States $0.018B 0.00
Benitec Biopharma (BNTC) United States $0.018B 0.00
VBI Vaccines (VBIV) United States $0.017B 0.00
Talis Biomedical (TLIS) United States $0.016B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.016B 0.00
Cocrystal Pharma (COCP) United States $0.016B 0.00
Aytu BioPharma (AYTU) United States $0.015B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.015B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
ABVC BioPharma (ABVC) United States $0.014B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
Senti Biosciences (SNTI) United States $0.014B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.013B 0.00
Imunon (IMNN) United States $0.013B 0.00
Purple Biotech (PPBT) Israel $0.012B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.012B 0.00
Monopar Therapeutics (MNPR) United States $0.011B 0.00
Eterna Therapeutics (ERNA) United States $0.011B 0.00
Galera Therapeutics (GRTX) United States $0.011B 0.00
Elevai Labs (ELAB) United States $0.010B 0.00
Moleculin Biotech (MBRX) United States $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Organovo Holdings (ONVO) United States $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
Telesis Bio (TBIO) United States $0.010B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.010B 0.00
AEterna Zentaris (AEZS) Canada $0.010B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
Biorestorative Therapies (BRTX) United States $0.009B 0.00
NuCana (NCNA) United Kingdom $0.008B 0.00
Virios Therapeutics (VIRI) United States $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.008B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.008B 0.00
Biofrontera (BFRI) United States $0.008B 0.00
Bionomics (BNOX) Australia $0.008B 0.00
TFF Pharmaceuticals (TFFP) United States $0.007B 0.00
Chemomab Therapeutics (CMMB) Israel $0.007B 0.00
Pasithea Therapeutics (KTTA) United States $0.007B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
Kineta (KA) United States $0.007B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.007B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.007B 0.00
Trevena (TRVN) United States $0.007B 0.00
AquaBounty Technologies (AQB) United States $0.007B 0.00
Atrinsic (PTIX) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
Cadrenal Therapeutics (CVKD) United States $0.007B 0.00
Psyence Biomedical (PBM) United States $0.007B 0.00
Enveric Biosciences (ENVB) United States $0.007B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Novogen (KZIA) Australia $0.006B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
First Wave BioPharma (FWBI) United States $0.006B 0.00
Vaccinex (VCNX) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.005B 0.00
PaxMedica (PXMD) United States $0.005B 0.00
Kintara Therapeutics (KTRA) United States $0.005B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
Palisade Bio (PALI) United States $0.005B 0.00
Alzamend Neuro (ALZN) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
NexImmune (NEXI) United States $0.005B 0.00
Exicure (XCUR) United States $0.005B 0.32
Longeveron (LGVN) United States $0.005B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.004B 0.00
Seelos Therapeutics (SEEL) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
GENPREX (GNPX) United States $0.004B 0.00
Cingulate (CING) United States $0.004B 0.00
Portage Biotech (PRTG) $0.004B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
TRACON Pharmaceuticals (TCON) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Ensysce Biosciences (ENSC) United States $0.004B 0.00
Mustang Bio (MBIO) United States $0.004B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.004B 0.00
Biophytis SA (BPTS) France $0.004B 0.00
Invo BioScience (INVO) United States $0.004B 0.00
GeoVax Labs (GOVX) United States $0.004B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
ARAVIVE, INC (ARAV) United States $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
CNS Pharmaceuticals (CNSP) United States $0.002B 0.00
Notable Labs (NTBL) United States $0.002B 0.00
ThermoGenesis Holdings (THMO) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.002B 0.00
GRI Bio (GRI) United States $0.001B 0.00
Sunshine Biopharma (SBFM) United States $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.001B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
Allarity Therapeutics (ALLR) United States $0.000B 0.00
Aptevo Therapeutics (APVO) United States $0.000B 0.00
Sinovac Biotech (SVA) China $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00